Article

Active Surveillance of Prostate Cancer

Prostate cancer is the most common serious cancer in men and the second most common cause of death from cancer.

Prostate cancer is the most common serious cancer in men and the second most common cause of death from cancer. One in six men will be diagnosed with it during their lifetime resulting in about 200,000 new cases during the next 12 months. Despite the number of men affected, the prevention, diagnosis, and treatment of this disease probably are more controversial than any other cancer. Prostate Cancer: Reducing Your Risks explains both sides of the various controversies in an easy to understand manner. It provides you with balanced, unbiased information based on the best scientific studies available. Equipped with this information, you will be able to decide the best course of action to maximize your survival and your quality of life.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.